Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nanobiotix (NBTX) Long-Term Investments (2018 - 2025)

Nanobiotix has reported Long-Term Investments over the past 8 years, most recently at $505194.9 for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 16.44% year-over-year to $505194.9; the TTM value through Dec 2025 reached $505194.9, up 16.44%, while the annual FY2025 figure was $505194.9, 16.44% up from the prior year.
  • Long-Term Investments for Q4 2025 was $505194.9 at Nanobiotix, up from $462971.5 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $599727.2 in Q2 2021 and troughed at $296892.0 in Q4 2022.
  • A 5-year average of $424149.1 and a median of $404726.8 in 2022 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: plummeted 49.99% in 2022 and later skyrocketed 39.58% in 2025.
  • Year by year, Long-Term Investments stood at $593720.9 in 2021, then tumbled by 49.99% to $296892.0 in 2022, then grew by 8.36% to $321706.0 in 2023, then skyrocketed by 34.86% to $433849.7 in 2024, then increased by 16.44% to $505194.9 in 2025.
  • Business Quant data shows Long-Term Investments for NBTX at $505194.9 in Q4 2025, $462971.5 in Q2 2025, and $433849.7 in Q4 2024.